- Home
- KROS vs PFIS Comparison
KROS vs PFIS Comparison
Compare KROS & PFIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KROS | PFIS |
|---|---|---|
| Founded | 2015 | 1905 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 584.9M | 499.8M |
| IPO Year | 2020 | 1998 |
Fundamental Metrics
Financial Performance| Metric | KROS | PFIS |
|---|---|---|
| Price | $11.33 | $52.46 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 1 |
| Target Price | $22.25 | ★ $56.00 |
| AVG Volume (30 Days) | ★ 321.3K | 28.6K |
| Earning Date | 06-05-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 4.75% |
| EPS Growth | ★ 146.00 | N/A |
| EPS | 2.30 | ★ 4.69 |
| Revenue | ★ $243,864,000.00 | N/A |
| Revenue This Year | N/A | $12.01 |
| Revenue Next Year | N/A | $5.85 |
| P/E Ratio | ★ $4.92 | $11.23 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.12 | $39.00 |
| 52 Week High | $22.55 | $57.71 |
Technical Indicators
Market Signals| Indicator | KROS | PFIS |
|---|---|---|
| Relative Strength Index (RSI) | 15.63 | 45.24 |
| Support Level | N/A | $50.56 |
| Resistance Level | $15.21 | $57.71 |
| Average True Range (ATR) | 0.69 | 1.85 |
| MACD | -0.38 | -0.46 |
| Stochastic Oscillator | 8.53 | 36.23 |
Price Performance
Historical ComparisonAbout KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About PFIS Peoples Financial Services Corp.
Peoples Financial Services Corp is a bank holding company operating through its subsidiaries. The bank provides a full range of financial services. Its products and services include checking accounts, business accounts, savings accounts, loan products, money market accounts, mortgages, chip-enabled debit cards, credit card processing, and visa master card and advisory services. Its loan portfolio includes Commercial loans, which consist of commercial, commercial real estate, municipal, and other related tax-free loans; and retail loans, which include residential real estate and other consumer loans. The company mainly operates in the United States in Pennsylvania.